Sarah J. Nelson, PhD

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
nelson_sarah

Professor, Department of Radiology and Biomedical Imaging, UCSF; and Director, Surbeck Laboratory of Advanced Imaging
Margaret Hart Surbeck Distinguished Professorship in Advanced Imaging, UCSF

sarah.nelson@radiology.ucsf.edu

Phone: (415) 514-9242 (asst), 476-6383 (office)
Box 0775, UCSF
San Francisco, CA 94143-0775

View on UCSF Profiles


Education

University of Manchester, England, Hons. B.S., 1975, Mathematics
University of Heidelberg, West Germany, Dr.rer.Nat., 1982, Applied Math/Rad. Biol.
Fox Chase Cancer Center, Philadelphia, PA, Postdoc, 1985-87, NMR


Professional Experience

  • 1975-1978
    Systems Analyst/Applied Mathematician, EASAMS Ltd., Surrey, England
  • 1978
    Mathematics Teacher, Geroge Abbott School, Surrey, England
  • 1979-1982
    Research Fellow / Graduate Student of Special Research. Project 123 "Stochastic Mathematical Models." Department of Applied Mathematics, University of Heidelberg, West Germany
  • 1985-1987
    Postdoctoral Fellow, Biostatistics Laboratory, Fox Chase Cancer Center, Philadelphia, PA
  • 1987-1988
    Research Associate of NMR and Medical Spectroscopy, Fox Chase Cancer Center, Phila. PA
  • 1988-1990
    Associate Member, Dept. of NMR and Medical Spectroscopy, Fox Chase Cancer Center Phila. PA
  • 1990-1994
    Assistant Professor of Radiology, University of California, San Francisco, CA
  • 1995-1997
    Associate Director, Magnetic Resonance Science Center, UCSF, CA
  • 1994-2000
    Associate Professor of Radiology, University of California, San Francisco, CA
  • 1997-2003
    Scientific Director, Magnetic Resonance Science center, UCSF, CA
  • 1999-2001
    Visiting Professor of Bioengineering, University of California, Berkeley, CA
  • 2000-present
    Professor of Radiology, University of California, San Francisco. CA.
  • 2002-present
    Professor of Bioengineering, University of California, Berkeley CA.
  • 2002-present
    Chair, Division of Bioengineering, University of California, San Francisco, CA
  • 2003-present
    Director, Surbeck Laboratory of Advanced Imaging, University of California, San Francisco, CA
  • 2004-present
    Margaret Hart Surbeck Distinguished Professorship in Advanced Imaging, University of Califonria, San Francisco, CA.
  • 2005-present
    Director, Program in Bioengineering of UCSF School of Medicine, UCSF, CA

Selected Publications

  1. Nelson SJ, Kurhanewicz J, Vigneron DB, Larson PE, Harzstark AL, Ferrone M, van Criekinge M, Chang JW, Bok R, Park I, Reed G, Carvajal L, Small EJ, Munster P, Weinberg VK, Ardenkjaer-Larsen JH, Chen AP, Hurd RE, Odegardstuen LI, Robb FJ, Tropp J, Murray JA. Metabolic imaging of patients with prostate cancer using hyperpolarized [1-¹³C]pyruvate. Sci Transl Med. 2013 Aug 14; 5(198):198ra108.
    View on PubMed
  2. Barajas RF, Hess CP, Phillips JJ, Von Morze CJ, Yu JP, Chang SM, Nelson SJ, McDermott MW, Berger MS, Cha S. Super-resolution track density imaging of glioblastoma: histopathologic correlation. AJNR Am J Neuroradiol. 2013 Jul; 34(7):1319-25.
    View on PubMed
  3. Swisher CL, Larson PE, Kruttwig K, Kerr AB, Hu S, Bok RA, Goga A, Pauly JM, Nelson SJ, Kurhanewicz J, Vigneron DB. Quantitative measurement of cancer metabolism using stimulated echo hyperpolarized carbon-13 MRS. Magn Reson Med. 2014 Jan; 71(1):1-11.
    View on PubMed
  4. Nelson SJ, Ozhinsky E, Li Y, Park Iw, Crane J. Strategies for rapid in vivo 1H and hyperpolarized 13C MR spectroscopic imaging. J Magn Reson. 2013 Apr; 229:187-97.
    View on PubMed
  5. Lupo JM, Essock-Burns E, Molinaro AM, Cha S, Chang SM, Butowski N, Nelson SJ. Using susceptibility-weighted imaging to determine response to combined anti-angiogenic, cytotoxic, and radiation therapy in patients with glioblastoma multiforme. Neuro Oncol. 2013 Apr; 15(4):480-9.
    View on PubMed
  6. Li Y, Lupo JM, Parvataneni R, Lamborn KR, Cha S, Chang SM, Nelson SJ. Survival analysis in patients with newly diagnosed glioblastoma using pre- and postradiotherapy MR spectroscopic imaging. Neuro Oncol. 2013 May; 15(5):607-17.
    View on PubMed
  7. Ohliger MA, Larson PE, Bok RA, Shin P, Hu S, Tropp J, Robb F, Carvajal L, Nelson SJ, Kurhanewicz J, Vigneron DB. Combined parallel and partial fourier MR reconstruction for accelerated 8-channel hyperpolarized carbon-13 in vivo magnetic resonance Spectroscopic imaging (MRSI). J Magn Reson Imaging. 2013 Sep; 38(3):701-13.
    View on PubMed
  8. Essock-Burns E, Phillips JJ, Molinaro AM, Lupo JM, Cha S, Chang SM, Nelson SJ. Comparison of DSC-MRI post-processing techniques in predicting microvascular histopathology in patients newly diagnosed with GBM. J Magn Reson Imaging. 2013 Aug; 38(2):388-400.
    View on PubMed
  9. Hu S, Larson PE, Vancriekinge M, Leach AM, Park I, Leon C, Zhou J, Shin PJ, Reed G, Keselman P, von Morze C, Yoshihara H, Bok RA, Nelson SJ, Kurhanewicz J, Vigneron DB. Rapid sequential injections of hyperpolarized [1-¹³C]pyruvate in vivo using a sub-kelvin, multi-sample DNP polarizer. Magn Reson Imaging. 2013 May; 31(4):490-6.
    View on PubMed
  10. Park I, Hu S, Bok R, Ozawa T, Ito M, Mukherjee J, Phillips JJ, James CD, Pieper RO, Ronen SM, Vigneron DB, Nelson SJ. Evaluation of heterogeneous metabolic profile in an orthotopic human glioblastoma xenograft model using compressed sensing hyperpolarized 3D 13C magnetic resonance spectroscopic imaging. Magn Reson Med. 2013 Jul; 70(1):33-9.
    View on PubMed
  11. Barajas RF, Phillips JJ, Parvataneni R, Molinaro A, Essock-Burns E, Bourne G, Parsa AT, Aghi MK, McDermott MW, Berger MS, Cha S, Chang SM, Nelson SJ. Regional variation in histopathologic features of tumor specimens from treatment-naive glioblastoma correlates with anatomic and physiologic MR Imaging. Neuro Oncol. 2012 Jul; 14(7):942-54.
    View on PubMed
  12. Ozhinsky E, Vigneron DB, Chang SM, Nelson SJ. Automated prescription of oblique brain 3D magnetic resonance spectroscopic imaging. Magn Reson Med. 2013 Apr; 69(4):920-30.
    View on PubMed
  13. Bian W, Harter K, Hammond-Rosenbluth KE, Lupo JM, Xu D, Kelley DA, Vigneron DB, Nelson SJ, Pelletier D. A serial in vivo 7T magnetic resonance phase imaging study of white matter lesions in multiple sclerosis. Mult Scler. 2013 Jan; 19(1):69-75.
    View on PubMed
  14. Constantin A, Elkhaled A, Jalbert L, Srinivasan R, Cha S, Chang SM, Bajcsy R, Nelson SJ. Identifying malignant transformations in recurrent low grade gliomas using high resolution magic angle spinning spectroscopy. Artif Intell Med. 2012 May; 55(1):61-70.
    View on PubMed
  15. Ozturk-Isik E, Pirzkall A, Lamborn KR, Cha S, Chang SM, Nelson SJ. Spatial characteristics of newly diagnosed grade 3 glioma assessed by magnetic resonance metabolic and diffusion tensor imaging. Transl Oncol. 2012 Feb; 5(1):10-8.
    View on PubMed
  16. Wu B, Zhang X, Wang C, Li Y, Pang Y, Lu J, Xu D, Majumdar S, Nelson SJ, Vigneron DB. Flexible transceiver array for ultrahigh field human MR imaging. Magn Reson Med. 2012 Oct; 68(4):1332-8.
    View on PubMed
  17. Elkhaled A, Jalbert LE, Phillips JJ, Yoshihara HA, Parvataneni R, Srinivasan R, Bourne G, Berger MS, Chang SM, Cha S, Nelson SJ. Magnetic resonance of 2-hydroxyglutarate in IDH1-mutated low-grade gliomas. Sci Transl Med. 2012 Jan 11; 4(116):116ra5.
    View on PubMed
  18. Lupo JM, Li Y, Hess CP, Nelson SJ. Advances in ultra-high field MRI for the clinical management of patients with brain tumors. Curr Opin Neurol. 2011 Dec; 24(6):605-15.
    View on PubMed
  19. Wang C, Li Y, Wu B, Xu D, Nelson SJ, Vigneron DB, Zhang X. A practical multinuclear transceiver volume coil for in vivo MRI/MRS at 7 T. Magn Reson Imaging. 2012 Jan; 30(1):78-84.
    View on PubMed
  20. Pang Y, Xie Z, Xu D, Kelley DA, Nelson SJ, Vigneron DB, Zhang X. A dual-tuned quadrature volume coil with mixed ?/2 and ?/4 microstrip resonators for multinuclear MRSI at 7 T. Magn Reson Imaging. 2012 Feb; 30(2):290-8.
    View on PubMed

Go to UCSF Profiles, powered by CTSI